Abstract
Testicular germ cell tumours (TGCTs) may arise through a process of multi-step carcinogenesis, and loss of heterozygosity (LOH) at specific loci is likely to be an important early event, although this has not been studied in detail. In order to explore the pathogenetic relationships among TGCTs, we investigated the genetic changes in testicular tumours that exhibit a disease continuum through the precursor carcinoma in situ (CIS) to either seminoma (SE) and/or non-seminomatous germ cell tumour (NSGCT). Universal amplification has been performed on 87 TGCT specimens and 36 samples of CIS cells microdissected from single paraffin-embedded tumour sections from 40 patients, including multiple specimens of CIS and TGCT cells of varied histology microdissected from 24 individual patients. Seventy-seven microsatellite markers were used to assay these samples for LOH at candidate regions selected from the literature, mapping to 3q, 5q, 9p, 11p, 11q, 12q, 17p and 18q. Construction of deletion maps for each of these regions identified common sites of deletion at 3q27–q28, 5q31, 5q34–q35, 9p22–p21 and 12q22, which correlate with allelic losses we have also observed in the precursor CIS cells. Evidence for allelic loss at 3q27–q28 was observed in all of the embryonal carcinoma samples analysed. We conclude that inactivation of gene(s) within these regions are likely to be early events in the development and progression of TGCTs. These results also provide molecular evidence in support of the hypothesis that SE is an intermediate stage of development within a single neoplastic pathway of progression from CIS precursor cells to NSGCT. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Asada Y, Varnum DS, Frankel WN and Nadeau FJ (1994) A mutation in the Ter gene causing increased susceptibility to testicular teratomas maps to mouse chromosome 18. Nat Genet 6: 263–368
Atkin NB and Baker MC (1982) Specific chromosome change, i(12p), in testicular tumours?. Lancet 2: 1349
Batata MA, Chu FC, Hilaris BS, Whitmore WF and Golbey RB (1982) Testicular cancer in cryptorchids. Cancer 49: 1023–1030
Bredael JJ, Vugrin D and Whitmore WJ Jr (1982) Autopsy findings in 154 patients with germ cell tumours of the testis. Cancer 50: 548–551
Casa E and Kirkpatrick BW (1996) Evaluation of different amplification protocols for use in primer-extension preamplification. Biotechniques 20: 219–225
Castedo SMMJ, de Jong B, Oosterhuis JW, Seruca R, te Meerman GJ, Dam A and Schraffordt Koops H 1989a) Cytogenetic analysis of ten human seminomas. Cancer Res 49: 439–443
Castedo SMMJ, de Jong B, Oosterhuis JW, Seruca R, Idenburg VJS, Dam A, te Meerman GJ, Schraffordt-Koops H and Sleijfer DT 1989b) Chromosomal changes in human primary testicular nonseminomatous germ cell tumours. Cancer Res 49: 5696–5701
Crisan D and Mattson JC (1993) Retrospective DNA analysis using fixed tissue specimens. DNA Cell Biol 12: 455–464
Czaja JT and Ulbright TM (1992) Evidence for the transformation of seminoma to yolk sac tumour, with histogenetic considerations. Am J Clin Pathol 97: 468–477
Damjanov I (1989) Is seminoma a relative or a precursor of embryonal carcinoma?. Lab Invest 60: 1–3
De Graaff WE, Oosterhuis JW, de Jong B, Dam A, van Putten WLJ, Castedo SMMJ, Sleijfer DT and Schraffordt-Koops H (1992) Ploidy of testicular carcinoma in situ. Lab Invest 66: 166–168
de Jong B, Oosterhuis JW, Castedo SMMJ, Vos ATM and te Meerman GJ (1990) Pathogenesis of adult testicular germ cell tumours. A cytogenetic model. Cancer Genet Cytogenet 48: 143–167
Ewing J (1911) Teratoma testis and its derivatives. Surg Gynecol Obstet 12: 230–261
Faulkner SW and Leigh DA (1998) Universal amplification of DNA isolated from small regions of paraffin-embedded formalin-fixed tissue. Biotechniques 24: 47–50
Fosså SD, Nesland JM, Pettersen EO, Amellem O, Wæhre H and Heimdal K (1991) DNA ploidy in primary testicular cancer. Br J Cancer 64: 948–952
Friedman NB (1951) The comparative morphogenesis of extragenital and gonadal teratoid tumours. Cancer 4: 265–276
Gillis AJM, Looijenga LHJ, de Jong B and Oosterhuis JW (1994) Conality of combined testicular germ cell tumours of adults. Lab Invest 71: 874–878
International Testicular Cancer Linkage Consortium (1998) Candidate regions for testicular cancer susceptibility genes. APMIS 106: 64–72
Jacobsen GK, Hendriksen OB and von der Maase H (1981) Carcinoma in situ of testicular tissue adjacent to malignant germ cell tumours: a study of 10 cases. Cancer 47: 2660–2662
Kiss F and Jubasz J (1985) Testicular germ cell tumours, current problems of histogenesis and classification. Int Urol Nephrol 17: 85–95
Looijenga LHJ, Gillis AJM, van Putten WLJ and Oosterhuis JW (1993) In situ numeric analysis of centromeric regions of chromosomes 1, 12 and 15 of seminomas, nonseminomatous germ cell tumours, and carcinoma in situ of human testis. Lab Invest 68: 211–219
Lothe RA, Hastie N, Heimadal K, Fosså SD, Stenwig AE and Børresen AL (1993) Frequent loss of 11p13 and 11p15 loci in male germ cell tumours. Genes Chromosomes Cancer 7: 96–101
Mostert MC, Verkerk AJ, van de Pol M, Heighway J, Marynen P, Rosenberg C, van Kessel AG, van Echten J, de Jong B, Oosterhuis JW and Looijenga LH (1998) Identification of the critical region of 12p over-representation in testicular germ cell tumours of adolescents and adults. Oncogene 16: 2617–2627
Mostofi FK (1986) Pathology and germ cell tumours of the testis. Cancer 45: 1735–1754
Mostofi FK and Sobin LH (1977) Histological typing of testis tumours. InInternational histological classification of tumours No. 16 WHO: Geneva
Murty VVVS, Bosl GJ, Houldsworth J, Meyers M, Mukherjee AB, Reuter V and Chaganti RSK 1994a) Allelic loss and somatic differentiation in human male germ cell tumours. Oncogene 9: 2245–2251
Murty VVVS, Li R-G, Houldsworth J, Bronson DL, Reuter VE, Bosl GJ and Chaganti RSK 1994b) Frequent allelic deletions and loss of expression characterise the DCC gene in male germ cell tumours. Oncogene 9: 1–5
Murty VVVS, Renault B, Falk CT, Bosl GJ, Kucherlapati R and Chaganti RSK 1996a) Physical mapping of a commonly deleted region, the site of a candidate tumour suppressor gene, at 12q22 in human male germ cell tumours. Genomics 35: 562–570
Murty VVVS, Reuter VE, Bosl GJ and Chaganti RSK 1996b) Deletion mapping identifies loss of heterozygosity at 5p15.1–p15.2, 5q11 and 5q34–35 in human male germ cell tumours. Oncogene 12: 2719–2723
Oliver RTD (1987) HLA phenotype and clinicopathological behaviour of germ cell tumours: possible evidence for clonal evolution from seminomas to NSGCT. Int J Androl 10: 85–94
Oosterhuis JW and Looijenga LHJ (1993) The biology of human germ cell tumours: retrospective speculations and new prospectives. Eur Urol 23: 245–250
Oosterhuis JW, Castedo SMMJ, de Jong B, Cornelisse CJ, Dam A, Th Sleijfer D and Schraffordt-Koops H (1989) Ploidy of primary germ cell tumours of the testis: pathogenetic and clinical relevance. Lab Invest 60: 14–20
Paulson TG, Galipeau PC and Reid BJ (1999) Loss of heterozygosity analysis using whole genome amplification, cell sorting and fluorescence-based PCR. Genome Res 9: 482–491
Peng H-Q, Bailey D, Bronson D, Goss PE and Hogg D (1995) Loss of heterozygosity of tumour suppressor genes in testis cancer. Cancer Res 55: 2871–2875
Pierce GB and Abell MR (1970) Embryonal carcinoma of the testis. Pathol Annu 5: 27–60
Raghavan D, Sullivan AL, Peckham MJ and Neville AM (1982) Elevated serum alphafetoprotein and seminoma. Clinical evidence for a histologic continuum?. Cancer 50: 982–989
Rodriguez E, Houldsworth J, Reuter VE, Meltzer P, Zhang J, Trent JM, Bosl GJ and Chaganti RSK (1993) Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumours. Genes Chromosomes Cancer 8: 230–236
Sesterhenn IA (1985) The role of intratubular malignant germ cells in the histogenesis of germ cell tumours. In Germ Cell Tumours II: Proceedings of the Second Germ Cell Tumours Conference, Jones WG, Milford-Ward A, Anderson CK (eds) pp 25–35. Pergamon Press: New York
Shibata D, Hawes D, Li Z-H, Hernandez AM, Spruck CH and Nichols P (1992) Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction. Am J Pathol 141: 539–543
Skakkebæk NE, Bethelsen JG, Giwercman A and Muller J (1987) Carcinoma of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10: 19–28
Suijkerbuik RF, Sinke RJ, Meloni AM, Parrington JM, van Echten J, de Jong G, Oosterhuis JW, Sandberg AA and Geurts van Kessel A (1993) Over-representation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ cell tumours revealed by fluorescence in situ hybridization. Cancer Genet Cytogenet 70: 85–93
van der Maase H, Rorth M, Walbom-Jorgensen S, Sorensen BL, Christophersen IS, Hald T, Jacobsen GK, Bethelsen JG and Skakkebæk NE (1986) Carcinoma in situ of the contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br J Med 293: 1398–1401
Vogelstein B, Fearon ER, Stanley BA, Hamilton R, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM and Bos JL (1988) Genetic alterations during colorectal-tumour development. N Engl J Med 319: 525–532
Zhang L, Cui X, Schmitt K, Hubert R, Navidi W and Arnheim N (1992) Whole genome amplification from a single cell: Implications for genetic analysis. Proc Natl Acad Sci USA 89: 5847–5851
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Faulkner, S., Leigh, D., Oosterhuis, J. et al. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer 83, 729–736 (2000). https://doi.org/10.1054/bjoc.2000.1334
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2000.1334
Keywords
This article is cited by
-
Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma
Journal of Cancer Research and Clinical Oncology (2008)
-
Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes
Oncogene (2003)
-
Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours
Oncogene (2003)
-
Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer
Oncogene (2002)
-
Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors
Oncogene (2002)
